ERDRP-0519
ERDRP-0519 is an antiviral drug which is the first drug specifically developed to target the measles morbillivirus.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
ERDRP-0519 is an antiviral drug which is the first drug specifically developed to target the measles morbillivirus. It acts as an inhibitor of the viral enzyme RNA polymerase which is essential for viral replication, and in animal studies showed good oral bioavailability and protected ferrets from otherwise lethal doses of a morbillivirus when administered up to three days after infection.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1367088495 under CC BY-SA 4.0; modifications have been made.